HYTN Grows Exports With Cannabis Flower Sales To Australia
HYTN Innovations Inc. (CSE:HYTN) has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand pursuant to the company’s supply agreement with TCann Pty Ltd.
